Abstract
Purpose
To identify currently used patient-reported outcome measures (PROMs) to evaluate disability in breast cancer survivors (BC) and critically evaluate their content and measurement properties.
Methods
Four electronic databases (PubMed, EMBASE, CINAHL, Scopus and Google Scholar) were searched from 2001 to February 2021. PRISMA guidelines were followed. The content of the included PROM was evaluated by linking the items of the questionnaires to the International Classification of Functioning, Disability and Health (ICF) Core Set for BC using standard linking rules. Methodological quality and measurement properties were assessed using the COSMIN checklist. Qualitative synthesis was used to summarize the evidence on content validity and measurement properties. The overall quality of evidence on each measurement property was provided using GRADE principles.
Results
Ten eligible studies reported measurement properties of seven PROMs. The content of included PROMs mostly focused on disability (70% of items), and less on body function and structure (23%) or environmental factors (6%). There was high linkage to The Comprehensive Core Set for BC, Q-DASH (100%), UEFI (95%) and DASH (92%). The Core Set Unique Disability Representation for DASH, and WHODAS2 was 39% and BCSQ-BC, Lymph-ICF was 34%. BCSQ-BC, and Lymph-ICF represented 32, and 20% of the content of the Core Set for BC, respectively, however, the other questionnaires covered less than 20% of the content of the Core Set. High quality of evidence supports sufficient results for internal consistency, testretest, and measurement error for BCSQ-BC, Lymph-ICF, DASH and WHODAS2.
Conclusions
Despite a lack of evidence on all-important clinical measurement, two generic (DASH and WHODAS2) and two disease-specific (BCSQ-BC, Lymph-ICF) PROM demonstrated emerging evidence of adequate measurement properties. The stronger alignment of the BCSQ-BC to the breast cancer ICF core set makes it preferable is a disease-specific measure. The Lymph-ICF is recommended where lymphedema is a specific focus. The DASH and WHODAS2 might be most useful where patients with a variety of upper extremity conditions, including breast cancer survivors, are being evaluated in the clinic or research study.
Similar content being viewed by others
Availability of data and material
Not applicable.
Code availability
Not applicable.
References
Tarver T. Cancer facts and figures american cancer society (ACS). J Consum Health Internet. 2012;16(3):366–7.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68(6):394–424.
Ibrahim M, Muanza T, Smirnow N, Sateren W, Fournier B, Kavan P, et al. Time course of upper limb function and return-to-work post-radiotherapy in young adults with breast cancer: a pilot randomized control trial on effects of targeted exercise program. J Cancer Surviv. 2017;11(6):791–9.
Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, et al. Cancer treatment and survivorship statistics. CA: Cancer J Clin. 2019;69(5):363–85.
Mousavi SA, Kasaeian A, Pourkasmaee M, Ghavamzadeh A, Alimoghaddam K, Vaezi M, et al. Assessing the prognostic factors, survival, and recurrence incidence of triple negative breast cancer patients, a single center study in Iran. PLoS ONE. 2019;14(1):e0208701.
Rundquist PJ, Behrens BA, Happel AS, Kennedy K, Biggers L. Shoulder kinematics and function in breast cancer survivors with unilateral lymphedema: an observational study. Rehabilit Oncol. 2015;33(1):41–6.
Leblanc M, Stineman M, Demichele A, Stricker C, Mao JJ. Validation of QUICKDASH outcome measure in breast cancer survivors for upper extremity disability. Arch Phys Med Rehabil. 2014;95(3):493–8.
Smoot B, Wong J, Cooper B, Wanek L, Topp K, Byl N, et al. Upper extremity impairments in women with or without lymphedema following breast cancer treatment. J Cancer Surviv. 2010;4(2):167–78.
Brandt DE, Ho P-S, Chan L, Rasch EK. Conceptualizing disability in US national surveys: application of the world health organization’s (WHO) international classification of functioning, disability, and health (ICF) FRAMEWORK. Qual Life Res. 2014;23(10):2663–71.
Mayo NE, Poissant L, Ahmed S, Finch L, Higgins J, Salbach NM, et al. Incorporating the international classification of functioning, disability, and health (ICF) into an electronic health record to create indicators of function: proof of concept using the SF-12. J Am Med Inform Assoc. 2004;11(6):514–22.
Stucki G, Cieza A, Ewert T, Kostanjsek N, Chatterji S, Ustun TB. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabilit. 2002;24(5):281–282.
Shamley DR, Srinanaganathan R, Weatherall R, Oskrochi R, Watson M, Ostlere S, et al. Changes in shoulder muscle size and activity following treatment for breast cancer. Breast Cancer Res Treat. 2007;106(1):19–27.
Ewert T. Die internationale klassifikation der funktionsfähigkeit, behinderung und gesundheit (icf) als klassifikationshilfe der langfristigen krankheitsfolgen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 2012;55(4):459–67.
Khan F, Amatya B, Demetrios M, Pallant JF. Relevance and completeness of the international classification of functioning, disability and health (ICF) comprehensive breast canc er core set: the patient perspective in an australian community cohort. J Rehabil Med. 2012;44(7):570–80.
Miller KL. Patient centered care: A path to better health outcomes through engagement and activation. NeuroRehabilitation. [cites 2016 Oct 14] [cited 2021 Jul 8];39(4):465–70. Available from: https://pubmed.ncbi.nlm.nih.gov/27689606/
Brach M, Cieza A, Stucki G, Füßl M, Cole A, Ellerin BE, et al. ICF Core Sets for breast cancer. J Rehabilit Med Suppl. 2004;36:121–7.
Brockow T, Duddeck K, Geyh S, Schwarzkopf SR, Weigl M, Franke T, et al. Identifying the concepts contained in outcome measures of clinical trials on breast cancer using the international classification of functioning, disability and health as a reference. J Rehabil Med Suppl. 2004;44:43–8.
Jelsma J. Use of the international classification of functioning, disability and health: a literature survey. J Rehabil Med. 2009;41:1–12.
Hayes S, Battistutta D, Newman B. Objective and subjective upper body function six months following diagnosis of breast cancer. Breast Cancer Res Treat. 2005;94(1):1–10.
Yang EJ, Kim BR, Shin HI, Lim JY. Use of the international classification of functioning, disability and health as a functional assessment tool for breast cancer survivors. J Breast Cancer. 2012;15(1):43–50.
Harrington S, Michener LA, Kendig T, Miale S, George SZ. Patient-reported upper extremity outcome measures used in breast cancer survivors: A systematic review. Arch Phys Med Rehabilit. 2014;95(1):153–62 (W.B. Saunders).
MacDermid JC. ICF Linking and Cognitive interviewing are complementary. - Google Scholar. Frontiers in Rehabilitation Sciences. 2021 [cited 2021 Oct 15];2:1–15. Available from: https://scholar.google.com/scholar?hl=en&as_sdt=0%2C5&q=ICF+Linking+and+Cognitive+Interviewing+Are+Complementary+Methods+for+Optimizing+Content+Validity+of+Outcome+Measures%3A+An+Integrated+Methods+Review&btnG=
Prinsen CAC, Mokkink LB, Bouter LM, Alonso J, Patrick DL, de Vet HCW, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1147–57.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;29:372.
Cieza A, Fayed N, Bickenbach J, Prodinger B. Refinements of the ICF Linking Rules to strengthen their potential for establishing comparability of health information. [cited 2016 Feb 27] [cited 2021 Sep 22];41(5):574–83. Available from: https://www.tandfonline.com/doi/abs/https://doi.org/10.3109/09638288.2016.1145258
Cieza A, Geyh S, Chatterji S, Kostanjsek N, Üstün B, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med. 2005;37(4):212–8.
MacDermid JC. ICF Linkage indicators. 2014
Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures. Qual Life Res. 2018;27(5):1171–9.
Shafiee E, Farzad M, Karbalaei M. A systematic review of self-reported outcome measures assessing disability following hand and upper extremity conditions in persian population. Arch Bone Jt Surg. 2021;9(2):141.
Prinsen CAC, Vohra S, Rose MR, Boers M, Tugwell P, Clarke M, et al. How to select outcome measurement instruments for outcomes included in a “core outcome set” – a practical guideline. Trials. 2016;17(1):449.
Terwee CB, Bot SDM, de Boer MR, van der Windt DAWM, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
Shafiee E, MacDermid J, Farzad M, Karbalaei M. A systematic review and meta-analysis of patient-rated wrist (and Hand) evaluation (PRWE/PRWHE) measurement properties, translation, and/ or cross-cultural adaptation. Disabil Rehabilit. 2021. p. 1–15. https://doi.org/10.1080/09638288.2021.1970250.
Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53.
Bobos P, Nazari G, Lu Z, MacDermid JC. Measurement Properties of the hand grip strength assessment: a systematic review with meta-analysis. Arch Phys Med Rehabil. 2020;101(3):553–65.
Evans JD. Straightforward statistics for the behavioral sciences. - PsycNET. Thomson Brooks/Cole Publishing Co.1996
Shafiee E, MacDermid JC, Walton D, Vincent JI, Grewal R. Psychometric properties and cross-cultural adaptation of the patient-rated tennis elbow evaluation (PRTEE) a systematic review and meta-analysis. Disabil Rehabilit. 2021. p.1–16. https://doi.org/10.1080/09638288.2021.1938248.
Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3 rating the quality of evidence. J Clin Epidemiology. 2011;64(4):401–6.
Davies C, Brockopp D, Moe K. Internal consistency of the disability of arm, shoulder and hand (dash) outcome measure in assessing functional status among breast cancer survivors. Rehabilit Oncol. 2013;31(4):6–12.
Davies C, Brockopp D, Moe K. Test-retest and internal consistency of the disability of arm, shoulder and hand (DASH) outcome measure in assessing functional status among breast cancer survivors with lymphedema. Rehabilit Oncol. 2015;33(1):28–31.
Davies CC, Lengerich A, Bugajski A, Brockopp D. Detecting change in activity using the patient-specific functional scale with breast cancer survivors. Rehabilit Oncol. 2018;36(2):117–22.
Binkley JM, Stratford P, Kirkpatrick S, Farley CR, Okoli J, Gabram S. Estimating the reliability and validity of the upper extremity functional index in women after breast cancer surgery. Clin Breast Cancer. 2018;18(6):e1261–7.
Devoogdt N, Van Kampen M, Geraerts I, Coremans T, Christiaens M-R. Lymphoedema functioning, disability and health questionnaire (Lymph-ICF): reliability and validity. Phys Ther. 2011;91(6):944–57.
VriezeTessa D, VosLore, GebruersNick, GroefAn D, DamsLore, GuchtElien V der, et al. Revision of the lymphedema functioning, disability and health questionnaire for upper limb lymphedema (Lymph-ICF-UL) Reliability and Validity. 2019;17(3):347–55. https://home.liebertpub.com/lrb
Vrieze T De, Gebruers N, Nevelsteen I, Tjalma WAA, Thomis S, Groef A De, et al. Responsiveness of the lymphedema functioning, disability, and health questionnaire for upper limb lymphedema in patients with breast cancer-related lymphedema. 2020;18(4):365–73. https://home.liebertpub.com/lrb
Yang EJ, Shin E-K, Shin H-I, Lim J-Y. Psychometric properties of scale constructed from the international classification of functioning, disability and health (ICF) core set for breast cancer based on Rasch analysis. Support Care Cancer. 2014;22(10):2839–49.
Zhao HP, Liu Y, Li HL, Ma L, Zhang YJ, Wang J. Activity limitation and participation restrictions of breast cancer patients receiving chemotherapy: psychometric properties and validation of the Chinese version of the WHODAS 2.0. Qual Life Res. 2012;22(4):897–906.
Terwee CB, Prinsen CAC, Chiarotto A, Westerman MJ, Patrick DL, Alonso J, et al. COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a delphi study. Qual Life Res. 2018;27(5):1159–70.
de Carvalho FN, Bergmann A, Koifman RJ. Functionality in women with breast cancer: the use of international classification of functioning, disability and health (ICF) in clinical practice. J Phys Ther Sci. 2014;26(5):721–30.
Befort CA, Austin H, Klemp JR. Weight control needs and experiences among rural breast cancer survivors. Psychooncology. 2011;20(10):1069–75.
Bornbaum CC, Doyle PC, Skarakis-Doyle E, Theurer JA. A critical exploration of the international classification of functioning, disability, and health (ICF) framework from the perspective of oncology: recommendations for revision. J Multidiscip Healthc. 2013;8(6):75–86.
Harrington S, Padua D, Battaglini C, Michener LA, Giuliani C, Myers J, et al. Comparison of shoulder flexibility, strength, and function between breast cancer survivors and healthy participants. J Cancer Surviv. 2011;5(2):167–74.
Alpozgen AZ, Ozdincler AR, Karanlik H, Agaoglu FY, Narin AN. Effectiveness of pilates-based exercises on upper extremity disorders related with breast cancer treatment. Eur J Cancer Care. 2017;26(6):e12532s.
Lee BG, Kim JK, Choi SH, Ahn HC, Chung MS. Is immediate reconstruction after mastectomy in breast cancer patients beneficial to shoulder function? ANZ J Surg. 2018;88(4):363–8.
Levy EW, Pfalzer LA, Danoff J, Springer BA, McGarvey C, Shieh C, et al. Predictors of functional shoulder recovery at 1 and 12months after breast cancer surgery. Breast Cancer Res Treat. 2012;134(1):315–24.
Bao T, Cai L, Giles JT, Gould J, Tarpinian K, Betts K, et al. A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors. Breast Cancer Res Treat. 2013;138(1):167–74.
Ortiz A, Tirado M, Hughes DC, Gonzalez V, Song J, Mama SK, et al. Relationship between physical activity, disability, and physical fitness profile in sedentary Latina breast cancer survivors. Physiother Theory Pract. 2018;334(10):783–94. https://doi.org/10.1080/09593985.2018.1424978.
Farzad M, MacDermid JC, Shafiee E, Beygi AS, Vafaei A, Varahra A, Beikpour H. Clinimetric testing of the persian version of the patient-rated tennis elbow evaluation (PRTEE) and the disabilities of the arm, shoulder, and hand (DASH) questionnaires in patients with lateral elbow tendinopathy. Disabil Rehabilit. 2020;1–6.
Acknowledgements
Joy MacDermid was supported by a Canada Research Chair and the Dr James Roth Chair (both in Musculoskeletal Measurement and Knowledge Translation).
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
All of the research team contributed to the study conception and study design. FJ and MF: contributed to the literature search, data extraction, quality assessment, and linkage between the content of the outcome measurements and the ICF framework. MF and FJ: mutually performed the analyses. AV: prepared the first draft of the manuscript, and MF: commented on each subsequent versions of the manuscript and did the final revisions. JCM: guided methods and revised the manuscript for important intellectual content. All authors read and approved the final manuscript to be published.
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare no conflict of interest with this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Jamshidi, F., Farzad, M., MacDermid, J.C. et al. Assessing the content based on ICF and quality based on COSMIN criteria of patient-reported outcome measures of functioning in breast cancer survivors: a systematic review. Breast Cancer 29, 377–393 (2022). https://doi.org/10.1007/s12282-022-01340-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12282-022-01340-6